Abstract:Abstract Purpose: The Bcl-2 family of proteins regulates a late step in the apoptosis pathway. Bcl-2 protein is believed to be involved in imparting resistance to programmed cell death or apoptosis induced by chemotherapeutic agents and radiation. The anti-apoptotic function of the Bcl-2 protein appears to be modulated by its ability to heterodimerize with other members of the gene family, predominantly Bax, a protein favouring induction of apoptosis. Susceptibility to undergoing apoptosis may, therefore, be dependent on the ratio between Bcl-2 and Bax. Both Bax and Bcl-2 are regulated by the tumour-suppressor protein p53. The present study therefore aims to study the significance of the Bcl-2:Bax ratio, p53 expression and apoptosis in paediatric acute lymphoblastic leukaemia (ALL). Methods: Expression of Bax, Bcl-2 and p53 was determined by immunocytochemistry, and apoptosis was evaluated by an enzymatic end-labelling technique using biotin-dUTP and further confirmed by annexin binding. The presence of mutant p53 was determined using a mutant-p53-specific enzyme-linked immunosorbent assay (ELISA). Results: A total of 32 cases and 20 controls were evaluated. Bcl-2 was found to be expressed in 22/32 of the ALL cases. Pretreatment (spontaneous) apoptosis was observed in 23/32 cases. The mean pretreatment apoptotic index was 11.34 ± 2.04% with a median value of 7.5%. Conclusions: There was a positive correlation between apoptosis and Bax expression (r = 0.5044; P = 0.0038). There was good correlation between the immunoreactivity of p53 and detection of mutant p53 by ELISA (r = 0.4605; P = 0.0079). The apoptosis index showed a negative borderline correlation to the expression of Bcl-2 protein (r = −0.3181; P = 0.076). There was an inverse correlation between extent of apoptosis and the presence of mutant p53 protein (r = −0.4732; P = 0.006). p53 protein expression also showed a correlation with both Bcl-2 (r = 0.4647; P = 0.007) and Bax (r = 0.4128; P = 0.018). The Bcl-2/Bax ratio, however, showed no significant correlation with apoptosis (r = −0.3131; P = 0.08) or with p53 expression. No significant association was evident between clinical and laboratory parameters with the Bcl-2/Bax protein expression except lymphadenopathy (r = 0.5774; P = 0.03). However, Bax expression showed a borderline correlation with the immediate tumour response to chemotherapy (r = −0.338; P = 0.0628). These patients are being followed-up to look for any association between clinical outcome, Bcl-2/Bax ratio and apoptosis.

Expression of Bcl-2, Bcl-XL, Bax and Bak in acute leukemia cells and its clinical significance

Clinical significance of Bcl-2 protein expression in adult acute leukemia

Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications]

The Studies of the Expression of Bcl-2, Bax and Fas/Apo-1 Genes in Acute Leukemia

The Clinical Significance of BCL-2 Gene Expression in Acute Leukemia

The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patients

Expression of Bcl-2 Gene in Acute Leukemia and Its Significance

Clinical Significance of the Expression of P-glycoprotein and Bcl-2 Protein in Acute Leukemia

Higher Expression of Cytochrome-c and Caspase-3 in the Primary Acute Lymphoblastic Leukemic Cells with Negative Expression of VEGF and Its Receptors Than with Positive Expressed Cells under VP16 Induction.

Expression of CD56 in acute leukemia and its clinical significance]

Relationship of anti-apoptosis gene bcl-xL and multidrug resistance in leukemia cells

Clinical significance of BECLIN1 and ATG5 expression in acute myeloid leukemia patients

Abstract 2532: Deciphering multiple protein complexes in BCL2 family to measure apoptotic dependencies in acute myeloid leukemia

Expression of Caspase-3 and Bcl-2 in leukaemia cell apoptosis and its significance in multiple-drug resistance

Expression of Bcl-2 and P170 in acute myelocytic leukemia and clinical significance

Relationship Between Expression of Apoptosis-modulating Proteins and Multidrug Resistance in K562/VCR Cells

BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy.

Transcript-Level Dysregulation of BCL2 Family Genes in Acute Myeloblastic Leukemia

Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia

Bcl-2 Gene and Its Family Genes Bax,Bcl-Xl As Well As Fas/Apo-1 and Their Clinical Significance in Acute Leukemia

Prognostic Significance Of B-Cell Lymphoma 2 Expression In Acute Leukemia: A Systematic Review And Meta-Analysis